Results 171 to 180 of about 12,353,923 (294)

Servitization strategies and Co-creation

, 2016
Purpose: This research aims at investigating the moderating role of co-creation in the implementation of servitization strategies in the pharmaceutical industry.
Frias, D., Ruiz-Alba, J., Soares, A., Rodriguez-Molina, M.   +3 more
core  

How host-guest interaction types shape value co-creation in urban tourism: The moderating role of AI technology stimuli. [PDF]

PLoS One
Chen G, Chen J.
europepmc   +1 more source

Mutant p53R273H disrupts PDPK1 homodimerization and contributes to PDPK1 activation

Molecular Oncology, EarlyView.
How mutant p53R273H drives AKT signaling is unclear. We show that p53R273H, but not wild‐type, directly binds PDPK1 via a mutation‐dependent conformational change. This interaction disrupts inhibitory PDPK1 homodimerization and enhances AKT phosphorylation.
Mei Chee Lim, Alvin Kunyao Guo, Yoko Itahana, Srinivasaraghavan Kannan, Valerie Goh, Mingmin Ong, Terina Yan Wen Tay, Weiying Ye, Sabhashina Radha Krishnan, Jun Nishiyama, Chandra S Verma, Koji Itahana   +11 more
wiley   +1 more source

From Social Media Content to Value Co-Creation: Role of Environmental Attitude, Environmental Knowledge, and Green Truth. [PDF]

Foods
Usiña-Báscones G, Carrión-Bósquez N, Samaniego-Arias M, Marchena-Chanduvi R, Medina-Miranda S, Zambrano-Vélez W, Ruiz-García W, Llamo-Burga M, Ortiz-Regalado O.   +8 more
europepmc   +1 more source

Enabling Value Co-Creation in Healthcare through Blockchain Technology. [PDF]

Int J Environ Res Public Health, 2022
Russo-Spena T, Mele C, Cavacece Y, Ebraico S, Dantas C, Roseiro P, van Staalduinen W.   +6 more
europepmc   +1 more source

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

Molecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba, Mark Shacker, Timothy P. Fleming, Michael A. Smith, Ross M. Bremner, Narendra V. Sankpal   +5 more
wiley   +1 more source

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

Molecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David, Arthur Karaulic, Audrey Bennetot, Clémence Fournier, Quentin Odet, Arthur Gouraud, Isabelle Bourget, Cédric Gaggioli, Sandy Giuliano, Frédéric Luciano, Olivier Léger, Zaki Sellam, Gilles Pagès   +12 more
wiley   +1 more source

The evolutionary game analysis of the decision-making behavior of live streaming stakeholders under the value co-creation. [PDF]

PLoS One, 2023
Jia S.
europepmc   +1 more source

Optimization of seminal extracellular vesicle isolation protocols for cancer biomarker analysis using proteomic profiling

Molecular Oncology, EarlyView.
This paper shows that size‐exclusion chromatography and sequential centrifugation applied to seminal plasma enrich for different populations of extracellular vesicles. This may significantly affect the detection and analysis of extracellular vesicle‐associated cancer biomarkers.
Elen Telumyan, Beatriz Martín‐Gracia, Eva Bassols‐Citores, Krizia Sagini, Maria K. Andersen, Tuula A. Nyman, May‐Britt Tessem, Morten B. Rye, Alicia Llorente   +8 more
wiley   +1 more source

Unpacking the mechanisms and consequences of artificial intelligence in enabling green value co-creation for SMEs. [PDF]

Sci Rep
Yan X, Chen YS, Lin Y.
europepmc   +1 more source